Dihydro-CDDO-Trifluoroethyl Amide (dh404), a Novel Nrf2 Activator, Suppresses Oxidative Stress in Cardiomyocytes
Open accessAbstract
Targeting Nrf2 signaling appears to be an attractive approach for the treatment of maladaptive cardiac remodeling and dysfunction; however, pharmacological modulation of the Nrf2 pathway in the cardiovascular system remains to be established. Herein, we report that a novel synthetic triterpenoid derivative, dihydro-CDDO-trifluoroethyl amide (dh404), activates Nrf2 and suppresses oxidative stress in cardiomyocytes. Dh404 interrupted the Keap1-Cul3-Rbx1 E3 ligase complex-mediated Nrf2 ubiquitination and subsequent degradation saturating the binding capacity of Keap1 to Nrf2, thereby rendering more Nrf2 to be translocated into the nuclei to activate Nrf2-driven gene transcription. A mutant Keap1 protein containing a single cysteine-to-serine substitution at residue 151 within the BTB domain of Keap1 was resistant to dh404-induced stabilization of Nrf2 protein. In addition, dh404 did not dissociate the interaction of Nrf2 with the Keap1-Cul3-Rbx1 E3 ligase complex. Thus, it is likely that dh404 inhibits the ability of Keap1-Cul3-Rbx1 E3 ligase complex to target Nrf2 for ubiquitination and degradation via modifying Cys-151 of Keap1 to change the conformation of the complex. Moreover, dh404 was able to stabilize Nrf2 protein, to enhance Nrf2 nuclear translocation, to activate Nrf2-driven transcription, and to suppress angiotensin II (Ang II)-induced oxidative stress in cardiomyocytes. Knockdown of Nrf2 almost blocked the anti-oxidative effect of dh404. Dh404 activated Nrf2 signaling in the heart. Taken together, dh404 appears to be a novel Nrf2 activator with a therapeutic potential for cardiac diseases via suppressing oxidative stress.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nrf2 protects cardiomyocytes from ROS-induced damage through the expression of antioxidant enzymes.
“Nrf2 has been shown to protect cardiomyocytes from ROS-induced damage through the expression of antioxidant enzymes [150,151]”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [151]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Nuclear Import and Export Signals in Control of Nrf2
Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502083200 · Cited by 194 · see citing works
RetractedProthymosin-α Mediates Nuclear Import of the INrf2/Cul3·Rbx1 Complex to Degrade Nuclear Nrf2
Niture, S. K., & Jaiswal, A. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808084200 · Cited by 66 · see citing works
RetractedCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · see citing works
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · see citing works
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · see citing works
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · see citing works
Self-citationPharmacology of oleanolic acid and ursolic acid
Liu, J. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)90032-2 · Cited by 1,431 · see citing works
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,262 · see citing works
Self-citationMechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,091 · see citing works
Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation
Kobayashi, M., & Yamamoto, M. P. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.385 · Cited by 1,075 · see citing works
Rothe, G., & Valet, G. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.5.440 · Cited by 870 · see citing works
Kobayashi, M., & Yamamoto, M. P. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.007 · Cited by 855 · see citing works
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., & Yamamoto, M. P. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00640.x · Cited by 817 · see citing works
Furukawa, M., & Xiong, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.162-171.2005 · Cited by 746 · see citing works
Pharmacological activities of natural triterpenoids and their therapeutic implications
Džubák, P., Hajdúch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M., & Šarek, J. (2006) · Natural Product Reports · doi:10.1039/b515312n · Cited by 707 · see citing works
Oyake, T., Itoh, K., Motohashi, H., Hayashi, N., Hoshino, H., Nishizawa, M., Yamamoto, M. P., & Igarashi, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6083 · Cited by 656 · see citing works
Kobayashi, M., Li, L., Iwamoto, N., Nakajima‐Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 641 · see citing works
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · see citing works
Erythroid transcription factor NF-E2 is a haematopoietic-specific basic–leucine zipper protein
Andrews, N. C., Erdjument‐Bromage, H., Davidson, M. B., Tempst, P., & Orkin, S. H. (1993) · Nature · doi:10.1038/362722a0 · Cited by 637 · see citing works
Panax ginseng pharmacology: A nitric oxide link?
Gillis, C. N. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00193-7 · Cited by 568 · see citing works
Nrf2, a multi‐organ protector?
Lee, J., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J., & Johnson, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2591hyp · Cited by 532 · see citing works
Self-citationNrf2 as a novel molecular target for chemoprevention
Lee, J., & Surh, Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 514 · see citing works
Nrf2 Defends the Lung from Oxidative Stress
Cho, H., Reddy, S. P., & Kleeberger, S. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.76 · Cited by 463 · see citing works
Ohba, M., Shibanuma, M., Kuroki, T., & Nose, K. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.4.1079 · Cited by 462 · see citing works
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J., Li, J., & Johnson, J. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2242 · Cited by 440 · see citing works
Self-citationBiosynthetic diversity in plant triterpene cyclization
Phillips, D. R., Rasbery, J. M., Bartel, B., & Matsuda, S. P. T. (2006) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2006.03.004 · Cited by 393 · see citing works
Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
Pacher, P., & Szabó, C. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080019 · Cited by 364 · see citing works
Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast.
Chan, J. Y., Han, X. L., & Kan, Y. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11371 · Cited by 342 · see citing works
The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 328 · see citing works
Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention
Hayes, J. D. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00695-4 · Cited by 323 · see citing works
Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducers
Kwak, M.-K., Wakabayashi, N., & Kensler, T. W. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.041 · Cited by 311 · see citing works
Kobayashi, A., Ito, E., Toki, T., Kogame, K., Takahashi, S., Igarashi, K., Hayashi, N., & Yamamoto, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6443 · Cited by 299 · see citing works
Yates, M. S., Tauchi, M., Katsuoka, F., Flanders, K. C., Liby, K. T., Honda, T., Gribble, G. W., Johnson, D. A., Johnson, J. A., Burton, N. C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0516 · Cited by 292 · see citing works
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Aleksunes, L. M., & Manautou, J. E. (2007) · Toxicologic Pathology · doi:10.1080/01926230701311344 · Cited by 285 · see citing works
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Li, J., Ichikawa, T., Villacorta, L., Janicki, J. S., Brower, G. L., Yamamoto, M. P., & Cui, T. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.189480 · Cited by 254 · see citing works
Self-citationThe cardiovascular continuum and renin–angiotensin–aldosterone system blockade
Dzau, V. J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000165623.72310.dd · Cited by 206 · see citing works
Walters, D. M., Cho, H., & Kleeberger, S. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1901 · Cited by 205 · see citing works
Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1089-1099.2005 · Cited by 173 · see citing works
He, X., Chen, M. G., Lin, G. X., & Ma, Q. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604120200 · Cited by 163 · see citing works
Thimmulappa, R. K., Fuchs, R. J., Malhotra, D., Scollick, C., Traore, K., Bream, J. H., Trush, M. A., Liby, K. T., Sporn, M. B., Kensler, T. W., et al. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1745 · Cited by 153 · see citing works
Villacorta, L., Zhang, J., Garcia-Barrio, M. T., Chen, X.-L., Freeman, B. A., Chen, Y. E., & Cui, T. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00261.2007 · Cited by 144 · see citing works
Self-citationLi, N., & Nel, A. E. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.88 · Cited by 130 · see citing works
Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang, Y., & Munday, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0625 · Cited by 111 · see citing works
Qin, F., Patel, R., Chen, Y., & Liu, W. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.010 · Cited by 104 · see citing works
Nrf2 Possesses a Redox-insensitive Nuclear Export Signal Overlapping with the Leucine Zipper Motif
Li, W., Jain, M. R., Chen, C., Yue, X., Hebbar, V., Zhou, R., & Kong, A.-N. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410601200 · Cited by 95 · see citing works
Gagnon, C., Leblond, F. A., & Filep, J. G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00741-8 · Cited by 63 · see citing works
Keap1 modification and nuclear accumulation in response to S-nitrosocysteine
Buckley, B. J., Li, S., & Whorton, A. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.055 · Cited by 61 · see citing works
Cui, T., Hironori Nakagami, A., Nahmias, C., Shiuchi, T., Takeda-Matsubara, Y., Li, J., Wu, L., Iwai, M., & Horiuchi, M. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0284 · Cited by 51 · see citing works
Self-citationPharmacological Activities of Natural Triterpenoids and Their Therapeutic Implications
Džubák, P., Hajdúch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M., & Šarek, J. (2006) · ChemInform · doi:10.1002/chin.200637244 · Cited by 34 · see citing works
Prisant, L. M. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.05.017 · Cited by 32 · see citing works
Xiong, Y., & Furukawa, M. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/95n4-1w77 · Cited by 31 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
Baird, L., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-20 · Cited by 1,600 · see citing works
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760 · see citing works
Kirkham, P. A., & Barnes, P. J. (2013) · Chest · doi:10.1378/chest.12-2664 · Cited by 685 · see citing works
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.003 · Cited by 622 · see citing works
Nrf2 at the heart of oxidative stress and cardiac protection
Chen, Q. M., & Maltagliati, A. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2017 · Cited by 474 · see citing works
Liby, K. T., & Sporn, M. B. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004846 · Cited by 410 · see citing works
Tan, Y., Ichikawa, T., Li, J., Si, Q., Yang, H., Chen, X., Goldblatt, C. S., Meyer, C. J., Li, X., Cai, L., et al. (2011) · Diabetes · doi:10.2337/db10-1164 · Cited by 393 · see citing works
Self-citationMolecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317 · see citing works
Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M., & Gribble, G. W. (2011) · Journal of Natural Products · doi:10.1021/np100826q · Cited by 312 · see citing works
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4826724 · Cited by 305 · see citing works
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Takaya, K., Suzuki, T., Motohashi, H., Onodera, K., Satomi, S., Kensler, T. W., & Yamamoto, M. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.023 · Cited by 277 · see citing works
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Cleasby, A., Yon, J. R., Day, P. J., Richardson, C. J., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R. A. E., Concha, N. O., Kerns, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098896 · Cited by 263 · see citing works
Marcotte, D. J., Zeng, W., Hus, J., McKenzie, A., Hession, C., Jin, P., Bergeron, C., Lugovskoy, A. A., Enyedy, I. J., Cuervo, H., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.019 · Cited by 245 · see citing works
NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
Boutten, A., Goven, D., Artaud-Macari, É., Boczkowski, J., & Bonay, M. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.006 · Cited by 223 · see citing works
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Bai, Y., Wang, X., Zhao, S., Ma, C., Cui, J., & Zheng, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/407580 · Cited by 204 · see citing works
Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice
Li, L., Zhang, X., Cui, L., Wang, L., Liu, H., Ji, H., & Du, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.032 · Cited by 192 · see citing works
Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases
da Costa, R. M., Rodrigues, D., Pereira, C. A., da Silva, J. F., Alves, J. V., Lobato, N. S., & Tostes, R. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00382 · Cited by 165 · see citing works
Nrf2 and Cardiovascular Defense
Howden, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104308 · Cited by 163 · see citing works
Wei, Y., Gong, J., Yoshida, T., Eberhart, C. G., Xu, Z., Kombairaju, P., Sporn, M. B., Handa, J. T., & Duh, E. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.026 · Cited by 143 · see citing works
The Nrf2 pathway in the progression of renal disease
Zoja, C., Benigni, A., & Remuzzi, G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft224 · Cited by 134 · see citing works
Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
Impellizzeri, D., Esposito, E., Attley, J., & Cuzzocrea, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.02.007 · Cited by 126 · see citing works
Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
Li, B., Liu, S., Miao, L., & Cai, L. (2012) · Experimental Diabetes Research · doi:10.1155/2012/216512 · Cited by 124 · see citing works
The role of natural products in revealing NRF2 function
Zhang, D. D., & Chapman, E. (2020) · Natural Product Reports · doi:10.1039/c9np00061e · Cited by 120 · see citing works
Tan, S. M., Sharma, A., Stefanovic, N., Yuen, D. Y. C., Karagiannis, T. C., Meyer, C. J., Ward, K. W., Cooper, M. E., & de Haan, J. B. (2014) · Diabetes · doi:10.2337/db13-1743 · Cited by 113 · see citing works
Self-citationTan, Y., Li, X., Prabhu, S. D., Brittian, K. R., Chen, Q., Yin, X., McClain, C. J., Zhou, Z., & Cai, L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.034 · Cited by 104 · see citing works
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects
Zoja, C., Corna, D., Nava, V., Locatelli, M., Abbate, M., Gaspari, F., Carrara, F., Sangalli, F., Remuzzi, G., & Benigni, A. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00376.2012 · Cited by 100 · see citing works
Sharma, A., Rizky, L., Stefanovic, N., Tate, M., Ritchie, R. H., Ward, K. W., & de Haan, J. B. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0513-y · Cited by 97 · see citing works
Lau, W. L., Liu, S., Pahlevan, S., Yuan, J. J., Khazaeli, M., Ni, Z., Chan, J. Y., & Vaziri, N. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3428-4 · Cited by 96 · see citing works
Keap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation
Kim, S., Lee, H.-G., Park, S., Kundu, J. K., Keum, Y., Cha, Y., Na, H., & Surh, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085984 · Cited by 94 · see citing works
Li, J., Zhang, C., Xing, Y., Janicki, J. S., Yamamoto, M. P., Wang, X. L., Tang, D., & Cui, T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr010 · Cited by 94 · see citing works
Self-citationThe Dark Side of Nrf2 in the Heart
Zang, H., Mathew, R. O., & Cui, T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00722 · Cited by 93 · see citing works
Self-citationZhang, F., Wang, S., Zhang, M., Weng, Z., Li, P., Gan, Y., Zhang, L., Cao, G., Gao, Y., Leak, R. K., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.647420 · Cited by 90 · see citing works
Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much?
Tan, S. M., & de Haan, J. B. (2014) · Redox Report · doi:10.1179/1351000214y.0000000087 · Cited by 86 · see citing works
Takagi, T., Kitashoji, A., Iwawaki, T., Tsuruma, K., Shimazawa, M., Yoshimura, S., Iwama, T., & Hara, H. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.009 · Cited by 81 · see citing works
Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target
Зенков, Н. К., Брониславовна, М. Е., & Tkachev, V. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913010033 · Cited by 81 · see citing works
Cytoprotective Effects of Natural Compounds against Oxidative Stress
Mehta, J., Rayalam, S., & Wang, X. (2018) · Antioxidants · doi:10.3390/antiox7100147 · Cited by 80 · see citing works
Aminzadeh, M. A., Reisman, S. A., Vaziri, N. D., Khazaeli, M., Yuan, J. J., & Meyer, C. J. (2013) · Xenobiotica · doi:10.3109/00498254.2013.852705 · Cited by 79 · see citing works
Self-citationAn essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes
Li, J., Ichikawa, T., Yu, J. H., Hofseth, L. J., Nagarkatti, P. S., Nagarkatti, M., Windust, A. J., & Cui, T. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.03.040 · Cited by 74 · see citing works
Self-citationNrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
Deliyanti, D., Alrashdi, S. F., Tan, S. M., Meyer, C. J., Ward, K. W., de Haan, J. B., & Wilkinson‐Berka, J. L. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22920 · Cited by 75 · see citing works
Self-citationBhakkiyalakshmi, E., Dornadula, S., Paulmurugan, R., & Ramkumar, K. M. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00378 · Cited by 71 · see citing works
Huerta, C., Jiang, X. J., Isaac, T., Bender, C. F., Ferguson, D. A., Probst, B., Swinger, K. K., Stoll, V. S., Thomas, P., Dulubova, I., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.026 · Cited by 69 · see citing works
Li, X.-H., Li, C., Zhi-gang, X., Hu, J., Lu, J.-M., Tian, R.-B., & Jia, W. P. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6415-z · Cited by 68 · see citing works
Passi, M., Shahid, S., Chockalingam, S., Sundar, I. K., & Packirisamy, G. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s242516 · Cited by 65 · see citing works
Amin, K. N., Bhakkiyalakshmi, E., Jayasuriya, R., Sarada, D. V. L., & Ramkumar, K. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104601 · Cited by 62 · see citing works
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins
Wang, W., Li, S., Wang, H., Li, B., Shao, L., Lai, Y., Horvath, G. C., Wang, Q., Yamamoto, M. P., Janicki, J. S., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.04.006 · Cited by 60 · see citing works
Self-citationXing, Y., Niu, T., Wang, W., Li, J., Li, S., Janicki, J. S., Ruiz, S., Meyer, C. J., Wang, X. L., Tang, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044899 · Cited by 61 · see citing works
Self-citationChin, M. P., Lee, C.-Y. I., Chuang, J.-C., Bumeister, R., Wigley, W. C., Sonis, S. T., Ward, K. W., & Meyer, C. J. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00387.2012 · Cited by 56 · see citing works
Self-citationWong, M. H. L., Bryan, H. K., Copple, I. M., Jenkins, R. E., Chiu, P. H., Bibby, J., Berry, N. G., Kitteringham, N. R., Goldring, C. E., O’Neill, P. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01292 · Cited by 56 · see citing works
Elucidating the Role of Protandim and 6‐Gingerol in Protection Against Osteoarthritis
Abusarah, J., Benabdoune, H., Shi, Q., Lussier, B., Martel‐Pelletier, J., Malo, M., Fernandes, J., de Souza, F. P., Fahmi, H., & Benderdour, M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25659 · Cited by 56 · see citing works
Chen, D., Li, Z., Bao, P., Chen, M., Zhang, M., Yan, F., Xu, Y., Ji, C., Hu, X., Sanchı́s, D., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.020 · Cited by 55 · see citing works
Choi, S. H., Park, S., Oh, C. J., Leem, J., Park, K., & Lee, I. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.07.005 · Cited by 55 · see citing works
Mapanga, R. F., Rajamani, U., Dlamini, N., Zungu-Edmondson, M., Kelly-Laubscher, R. F., Shafiullah, M., Wahab, A., Hasan, M. Y., Fahim, M. A., Rondeau, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047322 · Cited by 54 · see citing works
HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression
Hu, T., Schreiter, F. C., Bagchi, R. A., Tatman, P. D., Hannink, M., & McKinsey, T. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007006 · Cited by 50 · see citing works
Self-citationBjorkman, S. H., & Pereira, R. O. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8220 · Cited by 46 · see citing works
HIV-1, reactive oxygen species, and vascular complications
Porter, K. M., & Sutliff, R. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.019 · Cited by 45 · see citing works
Qu, C., Li, B., Lai, Y., Li, H., Windust, A. J., Hofseth, L. J., Nagarkatti, M., Nagarkatti, P. S., Wang, X. L., Tang, D., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.004 · Cited by 44 · see citing works
Self-citationEggler, A. L., & Savinov, S. N. (2013) · Springer eBooks · doi:10.1007/978-3-319-00581-2_7 · Cited by 42 · see citing works
Imai, T., Takagi, T., Kitashoji, A., Yamauchi, K., Shimazawa, M., & Hara, H. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.001 · Cited by 42 · see citing works
Bubb, K. J., Kok, C., Tang, O., Rasko, N. B., Birgisdottir, Å. B., Hansen, T., Ritchie, R. H., Bhindi, R., Reisman, S. A., Meyer, C. J., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.027 · Cited by 42 · see citing works
Self-citationDiabetic nephropathy: What does the future hold?
Montero, R., Covic, A. C., Gnudi, L., & Goldsmith, D. J. A. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1121-y · Cited by 41 · see citing works
Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology
Czibik, G., Dérumeaux, G., Sawaki, D., Valen, G., & Motterlini, R. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0450-9 · Cited by 39 · see citing works
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Daiber, A., Steven, S., Euler, G., & Schulz, R. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210125155821 · Cited by 40 · see citing works
Sugiyama, T., Imai, T., Nakamura, S., Yamauchi, K., Sawada, S., Shimazawa, M., & Hara, H. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.021 · Cited by 38 · see citing works
Deliyanti, D., Lee, J., Petratos, S., Meyer, C. J., Ward, K. W., Wilkinson‐Berka, J. L., & de Haan, J. B. (2016) · Clinical Science · doi:10.1042/cs20160068 · Cited by 36 · see citing works
Self-citationWu, X., Huang, L., & Liu, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10110 · Cited by 37 · see citing works
Wei, J., Zhu, H., Lord, G., Bhattachayya, M., Jones, B., Allaway, G. P., Biswal, S. S., Korman, B. D., Marangoni, R. G., Tourtellotte, W. G., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.002 · Cited by 36 · see citing works
Wong, D. P. W., Ng, M. Y., Leung, J. Y., Boh, B. K., Lim, E. C., Tan, S. H., Lim, S., Seah, W. H., Hu, C. Z., Ho, B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204853 · Cited by 33 · see citing works
Li, W., Wu, W., Song, H., Wang, F., Li, H., Chen, L., Lai, Y., Janicki, J. S., Ward, K. W., Meyer, C. J., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.046 · Cited by 32 · see citing works
Self-citationAdamson, R. J., Payne, N. C., Bartual, S. G., Mazitschek, R., & Bullock, A. N. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.021 · Cited by 31 · see citing works
Liu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 30 · see citing works
Tamir, T. Y., Bowman, B. M., Agajanian, M. J., Goldfarb, D., Schrank, T. P., Stohrer, T., Hale, A., Siesser, P. F., Weir, S., Murphy, R. M., et al. (2020) · Journal of Cell Science · doi:10.1242/jcs.241356 · Cited by 29 · see citing works
Role of Nrf2 and Its Activators in Cardiocerebral Vascular Disease
Cheng, L., Zhang, H., Wu, F., Liu, Z., Cheng, Y., & Wang, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4683943 · Cited by 24 · see citing works
Li, B., Abdalrahman, A., Lai, Y., Janicki, J. S., Ward, K. W., Meyer, C. J., Wang, X. L., Tang, D., & Cui, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.101 · Cited by 22 · see citing works
Self-citationPotential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
Lopez, A. J., Lau, H., Li, S., & Ichii, H. (2020) · Antioxidants · doi:10.3390/antiox9040321 · Cited by 22 · see citing works
Urolithin A ameliorates diabetic retinopathy via activation of the Nrf2/HO-1 pathway
Xu, Z., Li, S., Li, K., Wang, X., Li, X., An, M., Yu, X., Long, X., Zhong, R., Liu, Q., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0490 · Cited by 21 · see citing works
The triterpenoids of Ganoderma tsugae prevent stress‐induced myocardial injury in mice
Kuok, Q.-Y., Yeh, C., Su, B., Hsu, P., Ni, H., Liu, M., & Mo, F. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200704 · Cited by 21 · see citing works
Qin, A., Qin, J., Jin, Y., Xie, W., Fan, L., Jiang, L., & Mo, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.016 · Cited by 21 · see citing works
Kim, J., Park, H., Lee, J., & Kang, T. (2020) · Cells · doi:10.3390/cells9051123 · Cited by 20 · see citing works
Gatbonton-Schwager, T. N., Letterio, J. J., & Tochtrop, G. P. (2012) · Journal of Natural Products · doi:10.1021/np200823p · Cited by 19 · see citing works
Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice
Zhou, T., Qiu, S., Zhang, L., Li, Y., Zhang, J., Shen, D., Zhao, P., Yuan, L., Zhao, L., Duan, Y., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0109 · Cited by 18 · see citing works
La voie Nrf2 en pathologie respiratoire
Boutten, A., Goven, D., Artaud-Macari, É., & Bonay, M. (2011) · médecine/sciences · doi:10.1051/medsci/20112711012 · Cited by 17 · see citing works
Zhao, C. X., Cao, Y., Zhang, Y., & Qiao, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030752 · Cited by 16 · see citing works
Tao, T., Wang, X.-R., Liu, M., Xu, F., & Liu, X. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1081-1 · Cited by 15 · see citing works
Kim, M.-J., Park, H., Choi, S.-H., Kong, M.-J., Kim, J.-E., & Kang, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194862 · Cited by 14 · see citing works
Wang, M., Sheng, K.-J., Fang, J.-C., Zhao, H., Lu, S., Liu, Z., & Chen, B.-T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114829 · Cited by 14 · see citing works
Wang, N., Liu, X., Liu, K., Wang, K., & Zhang, H. (2023) · iScience · doi:10.1016/j.isci.2023.107443 · Cited by 12 · see citing works
Reisman, S. A., Ward, K. W., Klaassen, C. D., & Meyer, C. J. (2012) · Xenobiotica · doi:10.3109/00498254.2012.750022 · Cited by 12 · see citing works
Self-citationWu, H., Liu, Y., & Liu, C. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.06.011 · Cited by 8 · see citing works
Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases
Peng, D., Wang, A. H. J., Shi, W., & Lin, L. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01510-4 · Cited by 7 · see citing works
RTA dh404 Induces Cell Cycle Arrest, Apoptosis, and Autophagy in Glioblastoma Cells
Tsai, T., Su, Y., Tsai, C.-Y., Wu, C., Lee, K.-T., & Hsu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044006 · Cited by 6 · see citing works
Poore, D. D., Hofmann, G. A., Wolfe, L. A., Qi, H., Jiang, M., Fischer, M., Wu, Z., Sweitzer, T. D., Chakravorty, S. J., Donovan, B. T., et al. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218807698 · Cited by 6 · see citing works
Grün, B., Tirre, M., Pyschny, S., Singh, V. P., Kehl, H.-G., Jux, C., & Drenckhahn, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1011639 · Cited by 5 · see citing works
Taira, J., Tsuda, R., Miyagi‐Shiohira, C., Noguchi, H., & Ogi, T. (2023) · Antioxidants · doi:10.3390/antiox12030693 · Cited by 5 · see citing works
Histone Deacetylases and Oxidative Stress: Role in Diabetic Cardiomyopathy
Patel, B. M. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_18 · Cited by 5 · see citing works
Harris, R. C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00693.2012 · Cited by 4 · see citing works
Ishizaki, Y., Sasaki, K., Yoshikawa, T., Nakayoshi, T., Sasaki, M., Ohtsuka, M., Hatada-Katakabe, S., Takata, Y., & Fukumoto, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175422 · Cited by 2 · see citing works
Villeneuve, N. (2011) · UA Campus Repository (The University of Arizona)
Boutten, A., Goven, D., Artaud-Macari, É., & Bonay, M. (2011)
- Authors
- Ichikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T.
- Affiliations
- University of South Carolina (US)
- Reata Pharmaceuticals (United States) (US)
- University of Missouri (US)
- Corresponding author
- Hannink, Mark
- Cui, Taixing
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-21
- Volume
- 4
- Issue
- 12
- Pages
- e8391
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2791441
- OpenAlex
- W2040499888
- Cited by
- 99
- References
- 50
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 12 · 2013: 9 · 2012: 17
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- American Heart Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- Nrf2 activation, oxidative stress, cardiomyocytes, Keap1, Nrf2 ubiquitination, Nrf2 nuclear translocation, triterpenoid derivatives, angiotensin II, cardiac remodeling
- MeSH terms
- Animals, Animals, Newborn, Carrier Proteins, Cell Line, Cell Nucleus, Cytoskeletal Proteins, Humans, Hypertrophy, Myocardium, Oleanolic Acid, Transcription, Genetic, Reactive Oxygen Species, Oxidative Stress, Protein Transport, Reactive Nitrogen Species, Myocytes, Cardiac, Cullin Proteins, NF-E2-Related Factor 2, Mice, Rats, Ubiquitination, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review